Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
22nd Century Announces First Shipments of Pinnacle VLN® Products to Top 5 C-Store Chain Locations Across 12 States
-
Dogecoin Price Drops 30% – HashJ Launches Short-Term DOGE Contract Participation for Daily Crypto Returns
-
Darktrace Announces Opening of New Deployment Center and Corporate Office in Dallas, Texas, and Key Executive Hires
-
Sunrun Dispatches a Record Amount of Energy to California’s Grid During a Historic Event
-
Belite Bio to Host Webcast on August 11, 2025, to Discuss Second Quarter 2025 Financial Results
-
ContextLogic to Announce Second Quarter 2025 Results on August 7, 2025
-
DeFi Dev Corp. Purchases $18M SOL, Grows Treasury to 1.29M SOL
-
The Ether Machine Acquires Additional $40M in ETH, Bringing Total ETH Purchased and Committed to Over 345,000
-
Algorhythm Completes $4.5 Million Sale of Singing Machine Karaoke Business
-
INmune Bio’s CaRe PC Trial of INKmune™ in Metastatic Castration-Resistant Prostate Cancer Meets Endpoints and Is Closed to Enrollment
-
Stingray Acquires The Singing Machine Company to Bolster its In-Car Karaoke Offering with Integrated Microphones
-
CareCloud’s TalkEHR Approved for Use by Critical Access Hospitals, Unlocking $1.5B+ Inpatient Market
-
onsemi Reports Second Quarter 2025 Results
-
STAX Engineering Secures CARB Executive Order to Service Tanker Vessels throughout California
-
The Human Bean Turns Drink Purchases into Community Meals on August 8
-
iRocket Announces $640 Million Multi-Year Launch Agreement with SpaceBelt KSA to Deliver Secure and Autonomous Satellite Infrastructure for Saudi Arabia and Beyond
-
Freshworks to Participate in the Oppenheimer 28th Annual Technology, Internet & Communications Conference
-
Jefferson Capital to Announce Second Quarter 2025 Results
-
Westwood Announces Monthly Income Distributions for Westwood Salient Enhanced Midstream Income ETF (MDST) and Westwood Salient Enhanced Energy Income ETF (WEEI)
-
DSG Appoints Elizabeth Ubell to Board of Directors
-
Mural Oncology Announces Second Quarter Financial Results and Provides Business Update
-
ARS Pharmaceuticals Announces Conference Call and Webcast for its Second Quarter 2025 Financial Results
-
ZJK Industrial Co., Ltd. Triples Captive Screw Production Efficiency with New Semi-Automatic Equipment
-
Gabelli Funds to Host 31st Annual Aerospace & Defense Symposium at The Harvard Club, New York City Thursday, September 4, 2025
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
JDE Peet’s share buyback periodic update August 4, 2025
-
Arbe to Participate in Upcoming Investor Conferences
-
Lead Real Estate Co., Ltd Announces Sale of Two Apartment Hotels and Signing of Sales Contracts for Two Condominiums with Samurai Capital Co., Ltd
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PRIMARY HEALTH PROPERTIES - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - MITIE GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
-
ParaZero Technologies Ltd. Announces $2.2 Million Registered Direct Offering
-
Dimensional Fund Advisors Ltd. : Form 8.3 - ASSURA PLC - Ordinary Shares
-
Glass House Brands Provides Updates to Recent Events
-
UPCX Limited-Time Staking Event: Share a $16,000 Prize Pool + Unlimited Airdrops
-
Transactions in connection with share buyback programme
-
Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing
-
Tyson Foods Reports Third Quarter 2025 Results
-
Artelo Biosciences Announces $9.475 Million At-the-Market Private Placement to Initiate Solana Treasury Strategy, Becoming First Publicly-Traded Pharmaceutical Company to Adopt SOL as a Core Reserve A
-
Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy
-
Zevra Therapeutics Announces Details for Q2 2025 Financial Results Call
-
Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD)
-
XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right
-
MediWound to Report Second Quarter 2025 Financial Results
-
Digi Power X Reports 122% Month-Over-Month Increase in Cash and Crypto Position with No Long-Term Debt and Reports July 2025 Production Results
-
Stardust Power Announces Second Quarter 2025 Earnings Release Date, Conference Call
-
Mobiquity Technologies Launches CMOne – A Fully Agentic AI Marketing Platform for Unified Brand Engagement
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Transactions in connection with share buy-back program
-
Victus Global Launches $10 Million Fund to Back Emerging Low-Cap Blockchain Projects
